Scientific work

Doç. Dr. İstemi Serin

130 publications. The source of the information is stated next to each publication.

Back to profile

  1. Serum Aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: A single-centre study

    Mycoses, 2021

    DOI 10.1111/myc.13265 PMID 33683715 15 citations (Europe PMC) Source: ORCID

  2. Iron Overload During the Treatment of Acute Leukemia: Pretransplant Transfusion Experience

    International Journal of Hematologic Oncology, 2021

    DOI 10.2217/ijh-2021-0005 PMID 34840721 7 citations (Europe PMC) Open-access full textSource: ORCID

  3. Effect of the uncoupling protein-2 (UCP-2) and nuclear receptor subfamily 3 group C member 1 (NR3C1) genes on treatment efficacy and survival in patients with multiple myeloma: a single-center study

    BMC Research Notes, 2021

    DOI 10.1186/s13104-021-05758-7 PMID 34481515 Open-access full textSource: ORCID

  4. What are the roles of global DNA and APC 2 gene promotor hypermethylation in multiple myeloma?

    Molecular Biology Reports, 2021

    DOI 10.1007/s11033-021-06813-z PMID 34637096 4 citations (Europe PMC) Open-access full textSource: ORCID

  5. Evaluation of Intraventricular/Intrathecal Antimicrobial Therapy in the Treatment of Nosocomial Meningitis Caused by Multidrug-Resistant Gram-Negative Bacteria after Central Nervous System Surgery

    Canadian Journal of Infectious Diseases and Medical Microbiology, 2021

    DOI 10.1155/2021/9923015 PMID 34497678 3 citations (Europe PMC) Open-access full textSource: ORCID

  6. A new parameter in multiple myeloma: CYP3A4*1B single nucleotide polymorphism

    Annals of Hematology, 2021

    DOI 10.1007/s00277-020-04339-1 PMID 33170343 2 citations (Europe PMC) Open-access full textSource: ORCID

  7. A Case Report: Paroxysmal Nocturnal Hemoglobinuria and Systemic Lupus Erythematosus Association

    International Journal of Hematologic Oncology, 2021

    DOI 10.2217/ijh-2020-0013 PMID 34136122 3 citations (Europe PMC) Open-access full textSource: ORCID

  8. A new FLT3 inhibitor with two cases: the gilteritinib experience

    American Journal of Blood Research, 2021

    PMID 34322291 Open-access full textSource: ORCID

  9. DNA Repair Genes and Chronic Myeloid Leukemia: ERCC2 (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (-1394) Gene Polymorphisms

    Mediterranean Journal of Hematology and Infectious Diseases, 2021

    DOI 10.4084/mjhid.2021.020 PMID 33747401 3 citations (Europe PMC) Open-access full textSource: ORCID

  10. Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience

    BMC Oral Health, 2021

    DOI 10.1186/s12903-021-01634-9 PMID 34006261 4 citations (Europe PMC) Open-access full textSource: ORCID

  11. Comparison of Mitoxantrone–Melphalan and BEAM Conditioning Regimens in Patients with Lymphoma

    Hematology/Oncology and Stem Cell Therapy, 2021

    DOI 10.1016/j.hemonc.2021.03.005 PMID 33933474 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  12. A Rare Disease in the Differential Diagnosis of Chylothorax: Waldenström’s Macroglobulinaemia

    Istanbul Medical Journal, 2020

    DOI 10.4274/imj.galenos.2020.56750 Open-access full textSource: ORCID

  13. Evaluation of the Relationship Between Initial Lymphocyte Count and Molecular Response to Imatinib Therapy in Chronic Myeloid Leukaemia Patients

    Istanbul Medical Journal, 2020

    DOI 10.4274/imj.galenos.2020.46690 Open-access full textSource: ORCID

  14. A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality

    Journal of Infection and Public Health, 2020

    DOI 10.1016/j.jiph.2020.09.009 PMID 33071210 16 citations (Europe PMC) Open-access full textSource: ORCID

  15. An unexpected situation in isolated nasopharyngeal mass differential diagnosis: Solitary extramedullary plasmacytoma

    Otolaryngology Case Reports, 2020

    DOI 10.1016/j.xocr.2020.100246 1 citation (OpenAlex) Open-access full textSource: ORCID

  16. COVID-19 Pneumonia or Hypereosinophilic Syndrome?

    Journal of Medical Cases, 2020

    DOI 10.14740/jmc3587 PMID 33984086 2 citations (Europe PMC) Open-access full textSource: ORCID

  17. Recurrence of lymphoma with isolated pericardial mass: A case report

    Journal of Medical Case Reports, 2020

    DOI 10.1186/s13256-020-02508-4 PMID 33008468 4 citations (Europe PMC) Open-access full textSource: ORCID

  18. The miRNA 196a2 rs11614913 variant has prognostic impact on Turkish patients with multiple myeloma

    BMC Research Notes, 2020

    DOI 10.1186/s13104-020-05392-9 PMID 33228759 3 citations (Europe PMC) Open-access full textSource: ORCID

  19. Lenalidomide Plus Decitabine Treatment in a Myelodysplastic Syndrome Patient With Deletion 5q and Excess Blasts

    Journal of Hematology, 2020

    DOI 10.14740/jh618 PMID 32362984 2 citations (Europe PMC) Open-access full textSource: ORCID

  20. Prognostic Role of Lymphocyte/Monocyte Ratio in Chronic Lymphocytic Leukemia

    Journal of Hematology, 2020

    DOI 10.14740/jh730 PMID 33224391 6 citations (Europe PMC) Open-access full textSource: ORCID

  21. The relationship between serum ferritin level and fibrosis and splenomegaly in myelofibrosis

    American Journal of Blood Research, 2020

    PMID 33489443 Open-access full textSource: ORCID

  22. Retrospective Evaluation of Intravenous Immunoglobulin Use in Adult Hematology Practice

    American journal of pharmacological sciences, 2020

    DOI 10.12691/ajps-8-1-4 Open-access full textSource: OpenAlex

  23. COVID-19 Enfeksiyonunda Gelişmekte Olan Tedaviler

    Türkiye Klinikleri COVID - 19, 2020

    Source: OpenAlex

  24. Two Chronic Myeloid Leukemia Patients Presenting with Isolated Thrombocytosis

    International Journal of Innovative Research in Medical Science, 2020

    DOI 10.23958/ijirms/vol05-i08/938 Open-access full textSource: OpenAlex

  25. RETROSPECTIVE EVALUATION OF IVIG USE IN ADULT HEMATOLOGY PRACTICE

    2020

    DOI 10.22541/au.158567075.56695453 Open-access full textSource: OpenAlex

  26. DISEASE CHARACTERISTICS AND OUTCOME OF PATIENTS WITH RENAL ARTERY STENOSIS FOLLOWED BY A SINGLE NEPHROLOGY CENTER

    Nephrology Dialysis Transplantation, 2019

    Source: ORCID

  27. ETIOLOGICAL EVALUATION AND MORTALITY OF PATIENTS WITH RENAL ARTERY STENOSIS

    Nephrology Dialysis Transplantation, 2019

    Source: ORCID

  28. The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations

    Clinical Lymphoma Myeloma and Leukemia, 2019

    DOI 10.1016/j.clml.2019.03.028 PMID 31088736 4 citations (Europe PMC) Source: ORCID

  29. FP095ETIOLOGICAL EVALUATION AND MORTALITY OF PATIENTS WITH RENAL ARTERY STENOSIS

    Nephrology Dialysis Transplantation, 2019

    DOI 10.1093/ndt/gfz106.fp095 Source: OpenAlex

  30. SP065DISEASE CHARACTERISTICS AND OUTCOME OF PATIENTS WITH RENAL ARTERY STENOSIS FOLLOWED BY A SINGLE NEPHROLOGY CENTER

    Nephrology Dialysis Transplantation, 2019

    DOI 10.1093/ndt/gfz103.sp065 Open-access full textSource: OpenAlex